June 12, 2020 / 1:19 PM / a month ago

BRIEF-Pfenex Announces U.S. Commercial Launch Of Teriparatide Injection

June 12 (Reuters) - Pfenex Inc:

* PFENEX ANNOUNCES U.S. COMMERCIAL LAUNCH OF TERIPARATIDE INJECTION

* PFENEX INC - ANNOUNCED THAT ITS COMMERCIALIZATION PARTNER, ALVOGEN, HAS LAUNCHED TERIPARATIDE INJECTION IN UNITED STATES.

* PFENEX - TERIPARATIDE INJECTION IS A PRESCRIPTION MEDICINE APPROVED FOR POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WHO ARE AT HIGH RISK FOR HAVING BONE FRACTURES. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below